Cite
The Role of Combination Therapy with Mexiletine and Procainamide in Patients with Inducible Sustained Ventricular Tachycardia Refractory to Intravenous Procainamide.
MLA
Widerhorn, Josef, et al. “The Role of Combination Therapy with Mexiletine and Procainamide in Patients with Inducible Sustained Ventricular Tachycardia Refractory to Intravenous Procainamide.” Pacing & Clinical Electrophysiology, vol. 14, no. 3, Mar. 1991, pp. 420–26. EBSCOhost, https://doi.org/10.1111/j.1540-8159.1991.tb04090.x.
APA
Widerhorn, J., Sager, P. T., Rahimtoola, S. H., & Bhandari, A. K. (1991). The Role of Combination Therapy with Mexiletine and Procainamide in Patients with Inducible Sustained Ventricular Tachycardia Refractory to Intravenous Procainamide. Pacing & Clinical Electrophysiology, 14(3), 420–426. https://doi.org/10.1111/j.1540-8159.1991.tb04090.x
Chicago
Widerhorn, Josef, Philip T. Sager, Shahbudin H. Rahimtoola, and Anil K. Bhandari. 1991. “The Role of Combination Therapy with Mexiletine and Procainamide in Patients with Inducible Sustained Ventricular Tachycardia Refractory to Intravenous Procainamide.” Pacing & Clinical Electrophysiology 14 (3): 420–26. doi:10.1111/j.1540-8159.1991.tb04090.x.